Multiple drug hypersensitivity syndrome (MDH) should not be diagnosed by drug provocation tests

J Allergy Clin Immunol Pract. 2020 Feb;8(2):822-823. doi: 10.1016/j.jaip.2019.10.050.

Authors

Lukas Jörg¹, Daniel Yerly², Werner Pichler³

Affiliations

¹ Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: lukas.joerg@insel.ch.
² Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
³ ADR-AC GmbH, Adverse Drug Reactions, Analysis and Consulting, Bern, Switzerland.

PMID: 32037118
DOI: 10.1016/j.jaip.2019.10.050

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Asthma*
Drug Hypersensitivity Syndrome*
Drug Hypersensitivity*
Humans
Hypersensitivity*

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
dupilumab